📅 PUBMED DAILY TRIAGE — 2026-09-09 Window: 2026-09-08T00:00:00Z → 2026-09-09T09:00:00Z (CRDT) Topics scanned: 9 | Articles reviewed: 119 | Candidates evaluated: 119 High priority: 4 | Standard: 38 | Low/archive: 0 | Unsolicited finds: 3 Run status: SUCCESS
🔴🟠 HIGH PRIORITY (8+) — Best Finds by Topic
Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma)
No high-priority finds today (best candidate scored 7/10)
CBC-based diagnostics and machine learning in hematology
No high-priority finds today (best candidate scored 6/10)
Early cancer detection (liquid biopsy, ctDNA, cfDNA)
• PM42710275 · Liquid biopsy: a new window on the BRCA genes. · 7/10 · The Breast Cancer Susceptibility Gene (BRCA)-associated tumors represent a constantly evolving and i • PM42710536 · Clinical and pathological factors guide patient selection for electrochemotherapy in veter · 6/10 · Available data indicate that smaller tumors, lower disease burden, and earlier intervention are asso • PM42709018 · Evaluating adenoma detection and miss rates in tandem colonoscopy: Limitations of surrogat · 6/10 · S: We analyzed colonoscopy data from 356 patients (182 (51.12%) males and 174 (48.88%) females), rep • PM42710648 · The Double-Edged Sword of PD‑1/PD‑L1 Blockade: Bridging Hepatocellular Carcinoma to Liver · 5/10 · Until prospective trials pin down clear thresholds, clinicians will need to weigh oncologic risk aga
AI/ML in clinical diagnostics and imaging
No high-priority finds today (best candidate scored 7/10)
Precision oncology and genomic medicine
No high-priority finds today (best candidate scored 6/10)
Novel therapeutics: immunotherapy, CAR-T, targeted therapy
No high-priority finds today (best candidate scored 6/10)
Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk
No high-priority finds today (best candidate scored 7/10)
Aging, longevity, and population health
No high-priority finds today (best candidate scored 6/10)
Rare diseases with high unmet need
No high-priority finds today (best candidate scored 6/10)
🟢⚪ STANDARD (4-7) — Top by Topic
Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma)
• PM42709240 · Surgical outcomes and complications of fixation strategies for distal tibial fra · 7/10 · Genomics/Precision Medicine • PM42708703 · Clinical Outcomes of Younger Adults With Philadelphia-Negative Acute Lymphoblast · 7/10 · Treatment Innovation • PM42710088 · Age- and sex-adjusted genomic differences between Korean and Beat AML cohorts. · 6/10 · Genomics/Precision Medicine • PM42709169 · Sublingual apomorphine for Parkinsonian tremor: a post-hoc analysis of pivotal t · 6/10 · Other • PM42707149 · Successful distal splenic artery embolization in a patient with chronic lymphocy · 5/10 · Diagnostics
CBC-based diagnostics and machine learning in hematology
• PM42710145 · Construction of efficacy prediction model for T-DXd treatment of HER2-positive a · 6/10 · Diagnostics
Early cancer detection (liquid biopsy, ctDNA, cfDNA)
• PM42710649 · Predictive Biomarkers in Cancer Immunotherapy for Genitourinary Malignancies. · 6/10 · Treatment Innovation
AI/ML in clinical diagnostics and imaging
• PM42708063 · Early Risk Stratification of Severe Trauma in the Emergency Department: Integrat · 7/10 · Diagnostics • PM42709940 · Automated Extraction of Postoperative Cancer Recurrence and Metastasis From Comp · 6/10 · Diagnostics • PM42707805 · Emerging antimicrobial peptides in gastrointestinal disorders: Dual role in immu · 6/10 · Diagnostics • PM42707864 · Physiology-guided mechanical ventilation: Monitoring, proportional assist, and b · 5/10 · Diagnostics • PM42709992 · Sentence-Level Provenance for AI Medical Record Summarization in a Click-to-Insp · 5/10 · Diagnostics
Precision oncology and genomic medicine
• PM42710649 · Predictive Biomarkers in Cancer Immunotherapy for Genitourinary Malignancies. · 6/10 · Treatment Innovation • PM42708782 · Development of a biomarker-guided chemotherapy response model using combined CEA · 6/10 · Other • PM42708808 · Extracellular Matrix Remodeling in Tumors: Forces Beyond Fibroblasts. · 6/10 · Genomics/Precision Medicine • PM42708823 · Economic value and clinical role of minimally invasive, biopsy-based diagnostics · 5/10 · Genomics/Precision Medicine • PM42711224 · Targeting TP53 in triple-negative breast cancer: Molecular pathogenesis, therape · 5/10 · Genomics/Precision Medicine
Novel therapeutics: immunotherapy, CAR-T, targeted therapy
• PM42710649 · Predictive Biomarkers in Cancer Immunotherapy for Genitourinary Malignancies. · 6/10 · Treatment Innovation • PM42711068 · HIF1A(+)CSF3R(+) neutrophils-dominated hypoxic niche induced metabolic reprogram · 6/10 · Genomics/Precision Medicine • PM42710272 · Pseudoprogression in neoadjuvant immunotherapy for resectable NSCLC: a PET-CT-ba · 6/10 · Treatment Innovation • PM42709394 · Necrosis by Sodium Overload: Mechanisms, Pathophysiological Roles, and Therapeut · 6/10 · Treatment Innovation • PM42709325 · Assessment of the Value of Nivolumab Plus Ipilimumab for Treating Microsatellite · 6/10 · Other
Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk
• PM42710804 · Prognostic impact of an extravascular congestion score and its interaction with · 7/10 · Prevention • PM42711176 · Finerenone-Based Dual Versus Triple Therapy with SGLT2 Inhibitors and GLP-1 Rece · 6/10 · Prevention • PM42710812 · Association of tirzepatide with reverse cardiac remodeling and improved diastoli · 6/10 · Prevention • PM42710703 · Senotherapeutic Potential of Anti-Diabetic Medications: Bridging Type 2 Diabetes · 6/10 · Prevention • PM42710693 · Longitudinal associations between inflammatory biomarkers, polygenic risk scores · 6/10 · Prevention
Aging, longevity, and population health
• PM42711068 · HIF1A(+)CSF3R(+) neutrophils-dominated hypoxic niche induced metabolic reprogram · 6/10 · Genomics/Precision Medicine • PM42709964 · Performance, Failures, and Oversight of a Large Language Model Agent for Clinica · 6/10 · Public Health • PM42709274 · Pre- and post-COVID-19 changes in retinal disease patterns in Türkiye: insights · 6/10 · Public Health • PM42709261 · Exercise in Patients with Subclinical Atherosclerosis: Mechanisms, Clinical Evid · 5/10 · Prevention • PM42706471 · The Estrogen-CGRP Axis in Migraine: Neuroimmune Mechanisms, Sex Differences, and · 5/10 · Other
Rare diseases with high unmet need
• PM42707919 · Comparison of Cox Proportional Hazards Regression and Multiple Logistic Regressi · 6/10 · Genomics/Precision Medicine • PM42707213 · Case Report: Successful hematopoietic stem cell transplantation in pediatric pyr · 6/10 · Drug Development • PM42707628 · TRACE: A Framework for Integrating Transcript Relevance Into ACMG/AMP Variant In · 5/10 · Other
📊 TODAY'S BREAKDOWN
- By research category: Genomics/Precision Medicine: 8, Diagnostics: 8, Other: 8, Prevention: 6, Early Detection: 5, Treatment Innovation: 4, Public Health: 2, Drug Development: 1
- By evidence maturity: Exploratory: 42
- By source type: peer_reviewed 42 | preprint 0
- Topics with zero 8+ articles: CBC-based diagnostics and machine learning in hematology, AI/ML in clinical diagnostics and imaging, Novel therapeutics: immunotherapy, CAR-T, targeted therapy, Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk, Aging, longevity, and population health, Rare diseases with high unmet need
📊 By Watchlist Topic (reviewed / kept / highest score)
• Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma): 15 reviewed / 13 kept / best 7/10 • CBC-based diagnostics and machine learning in hematology: 1 reviewed / 1 kept / best 6/10 • Early cancer detection (liquid biopsy, ctDNA, cfDNA): 15 reviewed / 15 kept / best 7/10 • AI/ML in clinical diagnostics and imaging: 15 reviewed / 15 kept / best 7/10 • Precision oncology and genomic medicine: 15 reviewed / 15 kept / best 6/10 • Novel therapeutics: immunotherapy, CAR-T, targeted therapy: 15 reviewed / 15 kept / best 6/10 • Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk: 15 reviewed / 14 kept / best 7/10 • Aging, longevity, and population health: 15 reviewed / 15 kept / best 6/10 • Rare diseases with high unmet need: 3 reviewed / 3 kept / best 6/10 • Sentinel Scan (unsolicited finds): 10 reviewed / 10 kept / best 7/10
🔧 RUN NOTES
- Window: CRDT 2026-07-23 → 2026-09-09, no expansion triggered (all topics returned ≥1 result)
- CBC/ML hematology (T2): 1 result in window; the specified fallback was not needed because the primary query was nonzero
- Rare diseases (T9): 3 results in window, below the 15-candidate cap — reviewed all 3
- Sentinel scan: capped at 10; unsolicited finds flagged
- Scoring: rule-based heuristic v1.3 (conservative); abstract-level classification
- Run status: SUCCESS